🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

‘Chasing’ EVT with tenecteplase injection may lead to improved 90-day stroke outcomes neuronewsinternational.com/chasing-evt-wi…

The #MeVO #EVT trials were neutral😱 but that doesn't mean it's not important to diagnose MeVO stroke accurately!! Find out how to do it in this pictorial review🖼️ by Alex Stebner MD and team💡💡journals.sagepub.com/doi/10.1177/15…

Coverage of the two recent MT for medium vessel occlusion trials is now available at NEJM Journal Watch Neurology. DISTAL and ESCAPE MeVO discussed Urs Martin Fischer European Stroke Org World Stroke Org

The 55-85 rule for SBP reduction in acute ICH. In this retrospective analysis of ATACH-2, SPP reduction >55 mm Hg = better outcomes Reduction >70 = less ICH expansion But reduction >85 = more AKI Hence 55-85 is the sweet spot neurology.org/doi/10.1212/WN…

Persistent Tissue-Level Hypoperfusion (No-Reflow) Negates the Clinical Benefit of Successful Thrombectomy | Stroke ahajournals.org/doi/full/10.11…

📌 1. Stroke Mimics: Common Mimics: Seizures, migraines, conversion disorders Clinical Consideration: If ischemic stroke can't be confidently excluded within the treatment window, IVT can be safely administered. Outcome & Safety: Very low risk of symptomatic intracranial

Timeline of discovery of antibodies associated with autoimmune encephalitis. #AANAM from dr. Brian weinshenker.

Welcome to 𝕏, the group chat of Earth

Smoking doubles the risk of ischemic stroke. Quitting smoking is one of the best steps toward stroke prevention. #TobaccoFree #StrokeAwareness

Stroke is the #2 cause of death—yet missing from global health agendas. That must change. Proud to join as a founding member of the Global Stroke Action Coalition (GSAC) to demand action at the United Nations to Prioritize stroke & Expand access to thrombectomy youtu.be/Q1U-qeRBswc?si…

Interesting debate in NEJM on optimal treatment of device detected A FIB Luciano Sposato 🇦🇷🇨🇦 Canadian Stroke Consortium Ashkan Shoamanesh nejm.org/doi/full/10.10…

🧵 Supranuclear Eye Movement Disorders: Mastering Clinical Insight 👁️🧠 ⚠️ Heads‑up: It’s a long thread—but perfect for anyone eager to learn. Grab your coffee and scroll on! ☕😄

🧠💥 Time to Rethink Regulation in Stroke Care: Welcome to the NeuFDA Era 💥🧠 The FDA is evolving and so is our approach to advance neurovascular innovation. 📄 Read the posted article We are organizing an expert stakeholder coalition in September 2025. Stay tuned & connected!

The microcirculation is the key for success in treatment of acute large vessel occlusion stroke ahajournals.org/doi/abs/10.116…

CT Perfusion for Predicting Ischemic Stroke in Patients With Symptomatic Carotid or Middle Cerebral Artery Occlusion: A Post Hoc Analysis of the CMOSS Study | Stroke ahajournals.org/doi/full/10.11…

What is the difference bw futile recanalization and the no reflow phenomenon? Learn this and a lot more with the June issue of #strokealert podcast.

🩺 Need CME/CNE credits? 💻 Join Jacob Sambursky, M.D. tomorrow for "Navigating Dementia in Vascular Neurology" CME/CNE webinar! June 24 | 12 PM ET 🔗Register now: bit.ly/navigating-dem… #VascularNeurology #MedicalEducation #ContinuingEducation #BrainHealth #CognitiveHealth

ICYMI: We presented exciting updates on BB-031 at #ESOC2025, highlighting the RAISE trial—a Phase 2 patient study evaluating BB-031, a novel RNA aptamer that targets von Willebrand Factor (vWF) for the treatment of acute ischemic stroke. Learn more: 🔗 tinyurl.com/yc662r6h

Super important review as this is a very common inpatient consult

Join us tomorrow for ✨FREE CME✨ and a great discussion on cerebral amyloid angiopathy and vascular dementia! We’ll be live at 12pm EST with Dr. Jacob Sambursky, M.D.. Make sure to register below.